Promising long-term results of zolpidem treatment for the permanent vegetative state
This article has no abstract so we have provided the first paragraph of the full text.
Zolpidem is an omega-1-specific indirect 
-aminobutyric acid (GABA) agonist used to treat insomnia; this drug has also previously been reported to improve the condition of patients with brain disorders ranging from the permanent vegetative state (PVS) to stroke-induced aphasia. A recent study of patients categorized to the PVS who were given long-term treatment with the drug has now also reported very encouraging results.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.